Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Mallinckrodt
AstraZeneca
Johnson and Johnson
Moodys

Last Updated: November 22, 2019

DrugPatentWatch Database Preview

Details for Patent: 7,256,310

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 7,256,310
Title:Levalbuterol salt
Abstract:Levalbuterol L-tartrate affords crystals possessing properties desirable for use in a metered dose inhaler.
Inventor(s): McGlynn; Paul (Marlborough, MA), Bakale; Roger (Shrewsbury, MA), Sturge; Craig (Falmouth, CA)
Assignee: Sepracor Inc. (Marlborough, MA)
Application Number:10/728,873
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,256,310
Patent Claim Types:
see list of patent claims
Composition; Formulation; Delivery; Device; Process; Use;

Drugs Protected by US Patent 7,256,310

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Sunovion XOPENEX HFA levalbuterol tartrate AEROSOL, METERED;INHALATION 021730-001 Mar 11, 2005 RX Yes Yes   Start Trial   Start Trial Y Y TREATMENT OR PREVENTION OF BRONCHOSPASM OR ASTHMATIC SYMPTOMS   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,256,310

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 324364   Start Trial
Austria 498604   Start Trial
Australia 2003295695   Start Trial
Canada 2507572   Start Trial
Cyprus 1111330   Start Trial
Germany 60304900   Start Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Moodys
McKinsey
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.